During a session at the Heart in Diabetes CME Conference, speakers highlighted four papers recently published in Circulation ...

Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition ...

FDA seizes hundreds of fake Ozempic units from US supply after Novo Nordisk alerts regulators to counterfeit semaglutide ...

A market leader in the GLP-1 space, Novo Nordisk markets its semaglutide drugs under brand names Ozempic (pre-filled pen) and Rybelsus (oral tablet) for type II diabetes (T2D), and Wegovy ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight – without causing nausea. The discovery, made at the University of Gothenburg ...

So, the semaglutide franchise's total sales reached DKK 50 billion in the first quarter of 2025, an increase of 18.7% year-on-year. Novo Nordisk reached an important R&D milestone on May 14 ...

It's been a tough year for Novo Nordisk, the Danish pharmaceutical ... the weight-loss variant of its flagship drug semaglutide. For your first month of treatment, Reuters reports, you can nab ...

As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient resources to ensure safe access to Wegovy. Novo Nordisk has announced ...

The "Semaglutide Market Size, Share & Trends Analysis Report by Product (Ozempic, Wegovy, Rybelsus), Application (Type 2 Diabetes Mellitus, Obesity), Route of Administration, Distribution Channel, ...

PLAINSBORO, N.J. – Novo Nordisk Inc., a pharmaceutical giant with an impressive "GREAT" financial health rating according to InvestingPro, has launched a series of initiatives to combat the production ...